ATP13A2 (PARK9) polymorphisms influence the neurotoxic effects of manganese

Neurotoxicology. 2012 Aug;33(4):697-702. doi: 10.1016/j.neuro.2012.01.007. Epub 2012 Jan 20.

Abstract

Introduction: A higher prevalence of individuals affected by Parkinsonism was found in Valcamonica, Italy. This may be related to ferro-alloy smelters in the area, releasing manganese (Mn) in the air, soil and water for about a century. There exists individual susceptibility for Mn neurotoxicity.

Aim: To analyse how polymorphism in genes regulating Mn metabolism and toxicity can modify neurophysiological effects of Mn exposure.

Materials and methods: Elderly (N=255) and adolescents (N=311) from Northern Italy were examined for neuromotor and olfactory functions. Exposure to Mn was assessed in blood and urine by atomic absorption spectroscopy and in soil by a portable instrument based on X-Ray fluorescence technology. Polymorphisms in the Parkinson-related gene ATPase type 13A2 (ATP13A2, also called PARK9: rs3738815, rs2076602, rs4920608, rs2871776 and rs2076600), and in the secretory pathway Ca(2+)/Mn(2+) ATPase isoform 1 gene (SPCA1: rs218498, rs3773814 and rs2669858) were analysed by TaqMan probes.

Results: For both adolescents and elderly, negative correlations between Mn in soil and motor coordination (R(s)=-0.20, p<0.001; R(s)=-0.13, p=0.05, respectively) were demonstrated. Also among adolescents, negative correlations were seen between Mn in soil with odor identification (R(s)=-0.17, p<0.01). No associations were seen for Mn in blood or urine. ATP13A2 polymorphisms rs4920608 and rs2871776 significantly modified the effects of Mn exposure on impaired motor coordination in elderly (p for interaction=0.029, p=0.041, respectively), also after adjustments for age and gender. The rs2871776 altered a binding site for transcription factor insulinoma-associated 1.

Conclusions: ATP13A2 variation may be a risk marker for neurotoxic effects of Mn in humans.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Age Factors
  • Aged
  • Aged, 80 and over
  • Chi-Square Distribution
  • Child
  • Cross-Sectional Studies
  • Environmental Exposure / adverse effects*
  • Environmental Monitoring
  • Female
  • Gene-Environment Interaction
  • Genetic Predisposition to Disease
  • Humans
  • Iron / adverse effects*
  • Iron / blood
  • Iron / urine
  • Italy
  • Linear Models
  • Male
  • Manganese / adverse effects*
  • Manganese / blood
  • Manganese / urine
  • Manganese Poisoning / blood
  • Manganese Poisoning / diagnosis
  • Manganese Poisoning / enzymology
  • Manganese Poisoning / genetics*
  • Manganese Poisoning / physiopathology
  • Manganese Poisoning / urine
  • Middle Aged
  • Motor Activity / drug effects
  • Motor Activity / genetics
  • Multivariate Analysis
  • Neuropsychological Tests
  • Olfaction Disorders / chemically induced
  • Olfaction Disorders / physiopathology
  • Parkinson Disease, Secondary / blood
  • Parkinson Disease, Secondary / diagnosis
  • Parkinson Disease, Secondary / enzymology
  • Parkinson Disease, Secondary / genetics*
  • Parkinson Disease, Secondary / physiopathology
  • Parkinson Disease, Secondary / urine
  • Phenotype
  • Polymerase Chain Reaction
  • Proton-Translocating ATPases / genetics*
  • Proton-Translocating ATPases / metabolism
  • Residence Characteristics
  • Risk Assessment
  • Risk Factors
  • Smell / drug effects
  • Smell / genetics
  • Soil / chemistry
  • Soil Pollutants / adverse effects*
  • Soil Pollutants / blood
  • Soil Pollutants / urine
  • Spectrometry, X-Ray Emission
  • Spectrophotometry, Atomic

Substances

  • ATP13A2 protein, human
  • Soil
  • Soil Pollutants
  • ferro-manganese alloy
  • Manganese
  • Iron
  • Proton-Translocating ATPases